Literature DB >> 6133301

Sedative effects and prolactin response to single oral doses of melperone.

L Molander, L Borgström.   

Abstract

The pharmacokinetics of melperone and the relationship between plasma concentration and the effect on arousal and prolactin secretion after single oral doses (10, 25, 50 and 100 mg) was studied in normal subjects. Dose-dependent kinetics were indicated by the fact that higher plasma concentrations than expected were demonstrated after the 100-mg dose. Melperone decreased arousal and increased prolactin secretion in a dose-dependent manner. The level of arousal was correlated to melperone plasma concentration over the entire dose range. Prolactin secretion was also correlated to melperone plasma concentration, provided the relationship was studied separately for the individual melperone doses. Thus at higher doses, higher plasma concentrations are needed to elicit the same prolactin outflow. The possibility that reduced arousal reactions might contribute in the antipsychotic action of neuroleptic drugs was discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6133301     DOI: 10.1007/bf00427801

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency.

Authors:  G Langer; E J Sachar; P H Gruen; F S Halpern
Journal:  Nature       Date:  1977-04-14       Impact factor: 49.962

2.  Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain.

Authors:  S J Peroutka; D C U'Prichard; D A Greenberg; S H Snyder
Journal:  Neuropharmacology       Date:  1977-09       Impact factor: 5.250

3.  [The effect of methylperon (Eunerpan) on aggressive and auto-aggressive behaviour in mentally retarded patients--a double blind study (author's transl)].

Authors:  W Hacke; A Büssing; K Jungen
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1978-03

4.  Clinical assessment of dopamine receptor blockade.

Authors:  G Sedvall; L Bjerkenstedt; L Lindström; B Wode-Helgodt
Journal:  Life Sci       Date:  1978-08-07       Impact factor: 5.037

5.  A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood.

Authors:  I Creese; S H Snyder
Journal:  Nature       Date:  1977-11-10       Impact factor: 49.962

6.  A double-blind study of melperone and placebo in hospitalized chronic alcoholics in postintoxication phase.

Authors:  C Carlsson; B Gullberg; U Höstery; E Christensson
Journal:  Int J Clin Pharmacol Biopharm       Date:  1979-08

7.  Prolactin responses to neuroleptics in normal and schizophrenic subjects.

Authors:  P H Gruen; E J Sachar; G Langer; N Altman; M Leifer; A Frantz; F S Halpern
Journal:  Arch Gen Psychiatry       Date:  1978-01

8.  Psychophysiological and behavioral effects of phenothiazine administration in acute schizophrenics as a function of premorbid status.

Authors:  A LaPolla; M J Goldstein; L L Judd; E H Rodnick
Journal:  J Psychiatr Res       Date:  1969-05       Impact factor: 4.791

9.  Norepinephrine in chronic paranoid schizophrenia: above-normal levels in limbic forebrain.

Authors:  I J Farley; K S Price; E McCullough; J H Deck; W Hordynski; O Hornykiewicz
Journal:  Science       Date:  1978-04-28       Impact factor: 47.728

10.  Heterogeneity of human growth hormone and prolactin secreted in vitro: Immunoassay and radioreceptor assay correlations.

Authors:  J H Guyda
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

View more
  1 in total

1.  Development of orally disintegrating tablets comprising controlled-release multiparticulate beads.

Authors:  Gopi M Venkatesh; Phillip J Stevens; Jin-Wang Lai
Journal:  Drug Dev Ind Pharm       Date:  2012-02-23       Impact factor: 3.225

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.